Infliximab versus ciclosporin in severe ulcerative colitis.
Inflammatory Bowel Disease Center, Division of Gastroenterology, University of California San Diego, La Jolla, CA 92093-0956, USA.
Barrett G
BG
Levesque
William J
WJ
Sandborn
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000069285:Infliximab; D008297:Male; D013256:Steroids / Q000008:administration & dosage*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D013256:Steroids; D016572:Cyclosporine; D000069285:Infliximab